Sanofi SA vs United Airlines Holdings Inc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while United Airlines Holdings Inc trades at $117.71 (market cap $38.15B). The key difference: Sanofi SA is far larger — about 2.7× United Airlines Holdings Inc's market cap, and Sanofi SA pays a 5.5% dividend while United Airlines Holdings Inc pays none. Which is the better fit depends on your goals.
| SNY | UAL | |
|---|---|---|
Market Cap | $104.83B | $38.15B |
Sector | Health | Industrials |
52-Week High | $52.34 | $136.11 |
52-Week Low | $41.33 | $84.57 |
Enterprise Value | $121.32B | $55.18B |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →